Trials / Completed
CompletedNCT05527119
Phenotyping and Genotyping of Duffy Antigen
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Malaria remains the world's leading parasitic endemic. Almost half of the world's population lives in endemic areas. Many at-risk people in African countries remain without access to malaria control. Malaria kills approximately 400,000 people each year, most of whom are children under the age of 5 in Africa. Since 2005, an increasing number of Plasmodium vivax infections have been observed in Duffy-negative populations in South America and Africa, calling into question the essential role of the PvDBP-DARC interaction. The objective of the investigators is therefore to study and understand the invasion pathways used by Plasmodium vivax in Duffy-negative subjects.
Conditions
Timeline
- Start date
- 2022-03-11
- Primary completion
- 2023-07-11
- Completion
- 2023-09-11
- First posted
- 2022-09-02
- Last updated
- 2023-11-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05527119. Inclusion in this directory is not an endorsement.